# Characteristic metabolite profile of 10 colorectal cancer-related bacteria

**Authors:** Yongqiang Liu, Wangli Mei, Xinyan Huang, Xudong Yao, Cheng Kong, Yifan Chen

PMC · DOI: 10.3389/fonc.2025.1604876 · 2025-07-14

## TL;DR

This study identifies unique metabolite profiles in 10 CRC-related bacteria, which may help explain how these microbes influence cancer progression.

## Contribution

The study reveals distinct metabolite profiles and metabolic pathways in CRC-related bacteria, offering new insights into their role in cancer.

## Key findings

- Lactobacillus strains show increased saccharides and organic acids like galactinol and glutaric acid.
- Bifidobacterium strains exhibit significant changes in amino acids and derivatives such as glutamate and N-acetyl-5-hydroxytryptamine.
- CRC-related pathogens like ETEC and Fn show elevated bile acids and polyamines, indicating altered metabolic pathways.

## Abstract

Tumor metabolomics of colorectal cancer (CRC) is significantly different from normal tissues, due to nutrient deprivation, metabolite accumulation, acidity and hypoxia. Besides, gut microbiota has been confirmed to affect the progression of CRC. Microbiota metabolites might participate in the metabolic reprogramming of CRC cells and further regulate tumor microenvironment.

10 CRC-related strains are cultured in vitro (10 replicates per bacterium), including Enterotoxic Escherichia coli (ETEC), Peptostreptococcus anaerobius (Pa), Fusobacterium necroporum (Fne), Fusobacterium nucleatum (Fn), Lactobacillus plantarum (Lp), Lactobacillus acidophilus (La), Lactobacillus casei (Lc), Lactobacillus rhamnosus gg (LGG), Bifidobacterium bifidum (Bbi), Bifidobacterium Breve (Bbr). Bacterial culture supernatant is subjected to gas chromatography-mass spectrometry.

The 10 CRC-related strains have characteristic metabolite profiles, mainly referring to specific saccharides, amino acids, bile acids, polyamines and bioactive compounds. Saccharides and organic acids increase significantly in Lactobacillus (Lp, LA, Lc and LGG) compared with culture medium and other strains, such as galactinol, 1-ketose, beta-gentiobiose, glutaric acid, 3-phenyllactic acid, indlol-3-lactate. Chlorogenic acid, a beneficial polyphenol, increases significantly in Bbr. The abundance of amino acids and their derivatives changes significantly in Bifidobacterium (Bbi and Bbr), such as 2-hydroxy-2-methylbutanoic acid, N-acetyl-5-hydroxytryptamine and glutamate. Bile acids (lithocholic acid and cholic acid), polyamine (spermine), amino acids and derivatives (N-acetylaspartate, glutamate) increased significantly in the CRC-related pathogens (ETEC, Pa, Fn and Fne). Correspondingly, metabolic pathways are significantly affected, mainly including amino acid metabolism and nucleotide metabolism.

The 10 CRC-related strains possess significantly different metabolites and metabolic pathways. Specific metabolites and corresponding metabolic pathways might explain microbial CRC-promoting or -suppressing mechanisms.

## Linked entities

- **Chemicals:** galactinol (PubChem CID 11727586), glutaric acid (PubChem CID 743), 3-phenyllactic acid (PubChem CID 3848), chlorogenic acid (PubChem CID 1794427), 2-hydroxy-2-methylbutanoic acid (PubChem CID 95433), N-acetyl-5-hydroxytryptamine (PubChem CID 903), glutamate (PubChem CID 611), lithocholic acid (PubChem CID 9903), cholic acid (PubChem CID 221493), spermine (PubChem CID 1103), N-acetylaspartate (PubChem CID 65065)
- **Diseases:** colorectal cancer (MONDO:0005575)
- **Species:** Peptostreptococcus anaerobius (taxon 1261), Fusobacterium nucleatum (taxon 851), Lactobacillus acidophilus (taxon 1579), Bifidobacterium bifidum (taxon 1681), Bifidobacterium breve (taxon 1685)

## Full-text entities

- **Diseases:** Tumor (MESH:D009369), hypoxia (MESH:D000860), CRC (MESH:D015179)
- **Chemicals:** 3-phenyllactic acid (MESH:C017648), LA (MESH:D007811), glutaric acid (MESH:C035736), polyamine (MESH:D011073), 1-ketose (-), spermine (MESH:D013096), lithocholic acid (MESH:D008095), Chlorogenic acid (MESH:D002726), Saccharides (MESH:D002241), Bile acids (MESH:D001647), polyphenol (MESH:D059808), galactinol (MESH:C013536), N-acetyl-5-hydroxytryptamine (MESH:C006389), cholic acid (MESH:D019826), glutamate (MESH:D018698), amino acids (MESH:D000596), N-acetylaspartate (MESH:C000179)
- **Species:** Bifidobacterium bifidum (species) [taxon 1681], Fusobacterium nucleatum (species) [taxon 851], Lacticaseibacillus rhamnosus GG (strain) [taxon 568703], Lacticaseibacillus casei (species) [taxon 1582], Lactobacillus acidophilus (species) [taxon 1579], Bifidobacterium breve (species) [taxon 1685], Escherichia coli (E. coli, species) [taxon 562], Lactiplantibacillus plantarum (species) [taxon 1590], Peptostreptococcus anaerobius (species) [taxon 1261]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12301220/full.md

---
Source: https://tomesphere.com/paper/PMC12301220